GrafTech Reports First Quarter 2026 Results
Delivering Strong Sales Volume Growth
Reaffirming Full-Year Volume and Cost Expectations
Executing Pricing Actions and Other Strategic Initiatives to Support Long-term Value
First Quarter 2026 Summary
- Sales volume of 28.1 thousand MT, an increase of 14% year-over-year
-
Net sales of
$125 million , an increase of 12% year-over-year -
Net loss of
$43 million , or$1.66 per share(1) -
Adjusted EBITDA(2) of negative
$14 million -
Net cash used in operating activities of
$15 million -
Adjusted free cash flow(2) of negative
$27 million -
Total liquidity of
$329 million as ofMarch 31, 2026
CEO Comments
"We delivered 14% year-over-year sales volume growth in the first quarter and remain on track to meet our full-year volume expectation," said
"We are taking decisive steps to restore more sustainable market dynamics and support the long-term viability of our business and our industry," continued
First Quarter 2026 Financial Performance
|
(dollars in thousands, except per share amounts) |
|
||||||||
|
|
|||||||||
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
|||||||
|
Net sales |
$ |
125,101 |
|
$ |
116,457 |
|
$ |
111,839 |
|
|
Net loss |
$ |
(43,277 |
) |
$ |
(65,116 |
) |
$ |
(39,351 |
) |
|
Loss per share(1) |
$ |
(1.66 |
) |
$ |
(2.50 |
) |
$ |
(1.52 |
) |
|
Net cash used in operating activities |
$ |
(14,934 |
) |
$ |
(20,894 |
) |
$ |
(32,186 |
) |
|
|
|
|
|
||||||
|
Adjusted net loss(2) |
$ |
(53,527 |
) |
$ |
(63,886 |
) |
$ |
(34,155 |
) |
|
Adjusted loss per share(1)(2) |
$ |
(2.05 |
) |
$ |
(2.45 |
) |
$ |
(1.32 |
) |
|
Adjusted EBITDA(2) |
$ |
(13,550 |
) |
$ |
(21,900 |
) |
$ |
(3,672 |
) |
|
Adjusted free cash flow(2) |
$ |
(27,079 |
) |
$ |
(39,265 |
) |
$ |
(40,274 |
) |
Net sales for the first quarter of 2026 were
Net loss for the first quarter of 2026 was
For the first quarter of 2026, net cash used in operating activities was
Operational and Commercial Update
|
Key Operating Metrics |
|
|
|
|||
|
|
|
|
|
|||
|
(in thousands, except percentages) |
Q1 2026 |
Q4 2025 |
Q1 2025 |
|||
|
Sales volume (MT) |
28.1 |
|
27.1 |
|
24.7 |
|
|
Production volume (MT) |
29.4 |
|
27.8 |
|
28.5 |
|
|
Production capacity (MT)(3)(4) |
45.0 |
|
46.0 |
|
45.0 |
|
|
Capacity utilization(5) |
65 |
% |
60 |
% |
63 |
% |
Sales volume for the first quarter of 2026 was 28.1 thousand MT, an increase of 14% compared to the first quarter of 2025. For the first quarter of 2026, our weighted-average realized price was approximately
Production volume was 29.4 thousand MT for the first quarter of 2026, resulting in a capacity utilization rate of 65% for the quarter.
Capital Structure and Liquidity
As of
Outlook
Demand for graphite electrodes is expected to improve modestly in 2026, supported by stable-to-improving steel production trends outside of
While volume trends are stable, current industry-wide pricing levels do not reflect the indispensable nature of graphite electrodes for electric arc furcnace steelmaking. As a result, we are taking deliberate actions to restore more sustainable pricing and improve our profitability. These include implementing price increases of
On costs, geopolitical developments continue to impact key input costs, including oil-based raw materials, energy and logistics. In response, we are expanding initiatives to improve our cost structure, including enhancing production efficiency and optimizing production schedules. Factoring all of this in, we continue to expect a low single-digit percentage-point decline in our cash cost of goods sold per MT for 2026 compared to 2025.
We are also maintaining disciplined capital and working capital management. For 2026, we expect a modest increase in working capital for the full year to support higher volume. We continue to anticipate our full-year capital expenditures will be approximately
Longer term, we remain confident in the structural drivers of demand growth for graphite electrodes. The ongoing shift toward electric arc furnace steelmaking and growing demand for petroleum needle coke in battery applications are expected to support sustained industry growth. We believe the actions we are taking, combined with our vertical integration and a leading competitive position, will enable
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings call being held on
About
| _____________ | |
|
(1) |
Loss per share represents diluted loss per share. Adjusted loss per share represents diluted adjusted loss per share. All share and per share data presented have been retroactively adjusted for all periods to reflect a reverse stock split of our common stock at a ratio of 1-for-10, which became effective on |
|
(2) |
A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
|
(3) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
|
(4) |
Includes graphite electrode facilities in Calais, |
|
(5) |
Capacity utilization reflects production volume as a percentage of production capacity. |
|
(6) |
Gross debt reflects the notional value of our outstanding debt and excludes unamortized debt discount and issuance costs. |
|
(7) |
A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents ( |
Cautionary Note Regarding Forward-Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our Annual Report on Form 10-K and other filings with the
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release and in our Annual Report on Form 10-K that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Non‑GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted net loss, adjusted loss per share, free cash flow, adjusted free cash flow, net debt and cash cost of goods sold per MT are non-GAAP financial measures.
We define EBITDA, a non‑GAAP financial measure, as net loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA, a non-GAAP financial measure, as EBITDA adjusted by any pension and other post-employment benefit ("OPEB") expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities.
We define adjusted net loss, a non‑GAAP financial measure, as net loss, excluding the items used to calculate adjusted EBITDA and further excluding debt modification costs, less the tax effect of those adjustments and non-cash income tax expense related to the establishment of a deferred tax valuation allowance. We define adjusted loss per share, a non‑GAAP financial measure, as adjusted net loss divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net loss and adjusted loss per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
We define free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less capital expenditures. We define adjusted free cash flow, a non-GAAP financial measure, as free cash flow adjusted by payments made for debt modification costs. We use free cash flow and adjusted free cash flow as critical measures in the evaluation of liquidity in conjunction with related GAAP amounts. We also use these measures when considering available cash, including for decision-making purposes related to dividends and discretionary investments. Further, these measures help management, the Board of Directors, and investors evaluate the Company's ability to generate liquidity from operating activities.
We define net debt, a non-GAAP financial measure, as gross debt minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.
We define cash cost of goods sold per MT, a non-GAAP financial measure, as cost of goods sold less depreciation and amortization and less cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes, with this total divided by our sales volume measured in MT. We believe this is an important measure as it is used by our management and Board of Directors to evaluate our costs on a per MT basis.
In evaluating these non-GAAP financial measures, you should be aware that in the future, we may incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of these non-GAAP financial measures should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider these non-GAAP financial measures alongside other measures of financial performance and liquidity, including our net loss, loss per share, cash flow from operating activities, cost of goods sold and other GAAP measures.
|
|
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
(Dollars in thousands, except per share data) |
|||||||
|
(Unaudited) |
|||||||
|
|
|
|
|
||||
|
ASSETS |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
120,244 |
|
|
$ |
138,427 |
|
|
Accounts receivable, net of allowance for doubtful accounts of
|
|
79,912 |
|
|
|
73,235 |
|
|
Inventories |
|
223,115 |
|
|
|
224,692 |
|
|
Prepaid and other current assets |
|
42,926 |
|
|
|
48,180 |
|
|
Total current assets |
|
466,197 |
|
|
|
484,534 |
|
|
Property, plant and equipment |
|
985,093 |
|
|
|
986,946 |
|
|
Less: accumulated depreciation |
|
507,044 |
|
|
|
497,016 |
|
|
Net property, plant and equipment |
|
478,049 |
|
|
|
489,930 |
|
|
Deferred income taxes |
|
9,437 |
|
|
|
9,318 |
|
|
Other assets |
|
43,518 |
|
|
|
45,007 |
|
|
Total assets |
$ |
997,201 |
|
|
$ |
1,028,789 |
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
68,709 |
|
|
$ |
67,017 |
|
|
Accrued income and other taxes |
|
8,914 |
|
|
|
8,047 |
|
|
Other accrued liabilities |
|
40,955 |
|
|
|
48,363 |
|
|
Interest payable |
|
21,507 |
|
|
|
4,764 |
|
|
Total current liabilities |
|
140,085 |
|
|
|
128,191 |
|
|
|
|
|
|
||||
|
Long-term debt |
|
1,096,654 |
|
|
|
1,094,706 |
|
|
Other long-term obligations |
|
39,848 |
|
|
|
40,388 |
|
|
Deferred income taxes |
|
25,047 |
|
|
|
25,132 |
|
|
Stockholders’ deficit: |
|
|
|
||||
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
Common stock, par value |
|
2,584 |
|
|
|
2,582 |
|
|
Additional paid-in capital |
|
761,409 |
|
|
|
759,710 |
|
|
Accumulated other comprehensive loss |
|
(12,000 |
) |
|
|
(8,972 |
) |
|
Accumulated deficit |
|
(1,056,426 |
) |
|
|
(1,012,948 |
) |
|
Total stockholders’ deficit |
|
(304,433 |
) |
|
|
(259,628 |
) |
|
Total liabilities and stockholders’ deficit |
$ |
997,201 |
|
|
$ |
1,028,789 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
|
(Dollars in thousands, except per share data) |
|||||||
|
(Unaudited) |
|||||||
|
|
Three Months Ended
|
||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
|
|
|
|
||||
|
Net sales |
$ |
125,101 |
|
|
$ |
111,839 |
|
|
Cost of goods sold |
|
134,833 |
|
|
|
110,765 |
|
|
Lower of cost or market inventory valuation adjustment |
|
5,258 |
|
|
|
2,783 |
|
|
Gross loss |
|
(14,990 |
) |
|
|
(1,709 |
) |
|
Research and development |
|
1,443 |
|
|
|
1,879 |
|
|
Selling and administrative expenses |
|
14,228 |
|
|
|
14,622 |
|
|
Operating loss |
|
(30,661 |
) |
|
|
(18,210 |
) |
|
|
|
|
|
||||
|
Other (income) expense, net |
|
(12,048 |
) |
|
|
447 |
|
|
Interest expense |
|
24,196 |
|
|
|
29,841 |
|
|
Interest income |
|
(841 |
) |
|
|
(1,935 |
) |
|
Loss before income taxes |
|
(41,968 |
) |
|
|
(46,563 |
) |
|
Income tax expense (benefit) |
|
1,309 |
|
|
|
(7,212 |
) |
|
Net loss |
$ |
(43,277 |
) |
|
$ |
(39,351 |
) |
|
|
|
|
|
||||
|
Basic loss per common share: |
|
|
|
||||
|
Net loss per share |
$ |
(1.66 |
) |
|
$ |
(1.52 |
) |
|
Weighted average common shares outstanding |
|
26,089,860 |
|
|
|
25,837,005 |
|
|
Diluted loss per common share: |
|
|
|
||||
|
Net loss per share |
$ |
(1.66 |
) |
|
$ |
(1.52 |
) |
|
Weighted average common shares outstanding |
|
26,089,860 |
|
|
|
25,837,005 |
|
|
|
|
|
|
||||
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
(Dollars in thousands) |
|||||||
|
(Unaudited) |
|||||||
|
|
Three Months Ended
|
||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Cash flow from operating activities: |
|
|
|
||||
|
Net loss |
$ |
(43,277 |
) |
|
$ |
(39,351 |
) |
|
Adjustments to reconcile net loss to cash provided by (used in) operations: |
|
|
|
||||
|
Depreciation and amortization |
|
15,048 |
|
|
|
13,783 |
|
|
Deferred income tax expense (benefit) |
|
141 |
|
|
|
(7,310 |
) |
|
Non-cash stock-based compensation expense |
|
1,839 |
|
|
|
580 |
|
|
Non-cash interest expense |
|
1,948 |
|
|
|
1,948 |
|
|
Lower of cost or market inventory valuation adjustment |
|
5,258 |
|
|
|
2,783 |
|
|
Gain on sale of assets |
|
(12,279 |
) |
|
|
— |
|
|
Changes in assets and liabilities: |
|
|
|
||||
|
Accounts receivable, net |
|
(6,761 |
) |
|
|
5,396 |
|
|
Inventories |
|
(3,244 |
) |
|
|
(23,371 |
) |
|
Prepaid and other current assets |
|
4,629 |
|
|
|
(3,860 |
) |
|
Income taxes payable |
|
(254 |
) |
|
|
(866 |
) |
|
Accounts payable and other accruals |
|
5,530 |
|
|
|
103 |
|
|
Interest payable |
|
16,743 |
|
|
|
16,935 |
|
|
Change in Tax Receivable Agreement |
|
— |
|
|
|
(2,022 |
) |
|
Other |
|
(255 |
) |
|
|
3,066 |
|
|
Net cash used in operating activities |
|
(14,934 |
) |
|
|
(32,186 |
) |
|
Cash flow from investing activities: |
|
|
|
||||
|
Capital expenditures |
|
(12,145 |
) |
|
|
(10,281 |
) |
|
Proceeds from the sale of fixed assets |
|
9,315 |
|
|
|
29 |
|
|
Net cash used in investing activities |
|
(2,830 |
) |
|
|
(10,252 |
) |
|
Cash flow from financing activities: |
|
|
|
||||
|
Payments for taxes related to net share settlement of equity awards |
|
(339 |
) |
|
|
(213 |
) |
|
Principal payments under finance lease obligations |
|
(34 |
) |
|
|
(24 |
) |
|
Net cash used in financing activities |
|
(373 |
) |
|
|
(237 |
) |
|
Net change in cash and cash equivalents |
|
(18,137 |
) |
|
|
(42,675 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(46 |
) |
|
|
710 |
|
|
Cash and cash equivalents at beginning of period |
|
138,427 |
|
|
|
256,248 |
|
|
Cash and cash equivalents at end of period |
$ |
120,244 |
|
|
$ |
214,283 |
|
|
NON-GAAP RECONCILIATIONS |
|||||||||
|
(Dollars in thousands, except per share and per MT data) |
|||||||||
|
(Unaudited) |
|||||||||
|
The following tables reconcile our non-GAAP financial measures to the most directly comparable GAAP measures: |
|||||||||
|
|
|||||||||
|
Reconciliation of Net Loss to Adjusted Net Loss |
|||||||||
|
|
|
|
|
||||||
|
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
||||||
|
|
|
|
|
||||||
|
Net loss |
$ |
(43,277 |
) |
$ |
(65,116 |
) |
$ |
(39,351 |
) |
|
|
|
|
|
||||||
|
Diluted loss per common share: |
|
|
|
||||||
|
Net loss per share |
$ |
(1.66 |
) |
$ |
(2.50 |
) |
$ |
(1.52 |
) |
|
Weighted average shares outstanding |
|
26,089,860 |
|
|
26,043,244 |
|
|
25,837,005 |
|
|
|
|
|
|
||||||
|
Adjustments, pre-tax: |
|
|
|
||||||
|
Pension and OPEB plan expenses(1) |
|
531 |
|
|
(3,109 |
) |
|
628 |
|
|
Foreign currency remeasurement(2) |
|
(76 |
) |
|
867 |
|
|
(17 |
) |
|
Stock-based compensation expense(3) |
|
1,839 |
|
|
1,518 |
|
|
580 |
|
|
Gain on sale of assets(4) |
|
(12,279 |
) |
|
— |
|
|
— |
|
|
Tax Receivable Agreement adjustment(5) |
|
— |
|
|
— |
|
|
11 |
|
|
Debt modification costs(6) |
|
— |
|
|
— |
|
|
5,361 |
|
|
Total non-GAAP adjustments pre-tax |
|
(9,985 |
) |
|
(724 |
) |
|
6,563 |
|
|
Income tax impact on non-GAAP adjustments(7) |
|
265 |
|
|
(1,954 |
) |
|
1,367 |
|
|
Adjusted net loss |
$ |
(53,527 |
) |
$ |
(63,886 |
) |
$ |
(34,155 |
) |
|
Reconciliation of Loss Per Share to Adjusted Loss Per Share |
|||||||||
|
|
|
|
|
||||||
|
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
||||||
|
|
|
|
|
||||||
|
Loss per share |
$ |
(1.66 |
) |
$ |
(2.50 |
) |
$ |
(1.52 |
) |
|
Adjustments per share: |
|
|
|
||||||
|
Pension and OPEB plan expenses(1) |
|
0.02 |
|
|
(0.12 |
) |
|
0.02 |
|
|
Foreign currency remeasurement(2) |
|
— |
|
|
0.03 |
|
|
— |
|
|
Stock-based compensation expense(3) |
|
0.07 |
|
|
0.06 |
|
|
0.02 |
|
|
Gain on sale of assets(4) |
|
(0.47 |
) |
|
— |
|
|
— |
|
|
Tax Receivable Agreement adjustment(5) |
|
— |
|
|
— |
|
|
— |
|
|
Debt modification costs(6) |
|
— |
|
|
— |
|
|
0.21 |
|
|
Total non-GAAP adjustments pre-tax per share |
|
(0.38 |
) |
|
(0.03 |
) |
|
0.25 |
|
|
Income tax impact on non-GAAP adjustments per share(7) |
|
0.01 |
|
|
(0.08 |
) |
|
0.05 |
|
|
Adjusted loss per share |
$ |
(2.05 |
) |
$ |
(2.45 |
) |
$ |
(1.32 |
) |
|
Reconciliation of Net Loss to Adjusted EBITDA |
|||||||||
|
|
|
|
|
||||||
|
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
||||||
|
|
|
|
|
||||||
|
Net loss |
$ |
(43,277 |
) |
$ |
(65,116 |
) |
$ |
(39,351 |
) |
|
Add: |
|
|
|
||||||
|
Depreciation and amortization |
|
15,048 |
|
|
15,799 |
|
|
13,783 |
|
|
Interest expense |
|
24,196 |
|
|
24,281 |
|
|
29,841 |
|
|
Interest income |
|
(841 |
) |
|
(1,448 |
) |
|
(1,935 |
) |
|
Income taxes |
|
1,309 |
|
|
5,308 |
|
|
(7,212 |
) |
|
EBITDA |
|
(3,565 |
) |
|
(21,176 |
) |
|
(4,874 |
) |
|
Adjustments: |
|
|
|
||||||
|
Pension and OPEB plan expenses(1) |
|
531 |
|
|
(3,109 |
) |
|
628 |
|
|
Foreign currency remeasurement(2) |
|
(76 |
) |
|
867 |
|
|
(17 |
) |
|
Stock-based compensation expense(3) |
|
1,839 |
|
|
1,518 |
|
|
580 |
|
|
Gain on sale of assets(4) |
|
(12,279 |
) |
|
— |
|
|
— |
|
|
Tax Receivable Agreement adjustment(5) |
|
— |
|
|
— |
|
|
11 |
|
|
Adjusted EBITDA |
$ |
(13,550 |
) |
$ |
(21,900 |
) |
$ |
(3,672 |
) |
|
Reconciliation of |
|||||||||
|
|
|
|
|
||||||
|
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
||||||
|
|
|
|
|
||||||
|
Net cash used in operating activities |
$ |
(14,934 |
) |
$ |
(20,894 |
) |
$ |
(32,186 |
) |
|
Capital expenditures |
|
(12,145 |
) |
|
(18,371 |
) |
|
(10,281 |
) |
|
Free cash flow |
|
(27,079 |
) |
|
(39,265 |
) |
|
(42,467 |
) |
|
|
|
|
|
||||||
|
Debt modification costs(8) |
|
— |
|
|
— |
|
|
2,193 |
|
|
Adjusted free cash flow |
$ |
(27,079 |
) |
$ |
(39,265 |
) |
$ |
(40,274 |
) |
|
Reconciliation of Cost of Goods Sold to Cash Cost of Goods Sold per MT |
||||||
|
|
|
|||||
|
|
Q1 2026 |
Q4 2025 |
Q1 2025 |
|||
|
|
|
|
|
|||
|
Cost of goods sold |
$ |
134,833 |
$ |
128,805 |
$ |
110,765 |
|
Less: |
|
|
|
|||
|
Depreciation and amortization(9) |
|
13,477 |
|
14,229 |
|
12,144 |
|
Cost of goods sold - by-products and other(10) |
|
13,238 |
|
5,672 |
|
8,415 |
|
Cash cost of goods sold |
|
108,118 |
|
108,904 |
|
90,206 |
|
Sales volume (in thousands of MT) |
|
28.1 |
|
27.1 |
|
24.7 |
|
Cash cost of goods sold per MT |
$ |
3,848 |
$ |
4,019 |
$ |
3,652 |
|
(1) |
Net periodic benefit cost for our pension and OPEB plans, including a mark-to-market adjustment, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year. |
|
(2) |
Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(3) |
Non-cash expense for stock-based compensation awards. |
|
(4) |
Gain recognized related to the sale of assets associated with previously divested operations. |
|
(5) |
Prior to the second quarter of 2025, when the Company established a full valuation allowance, represents expense adjustment for future payment to our sole pre-Initial Public Offering stockholder for tax assets that have been utilized. |
|
(6) |
Debt modification costs related to the |
|
(7) |
Represents the tax impact on the non-GAAP adjustments. |
|
(8) |
Cash payments of debt modification costs related to the |
|
(9) |
Reflects the portion of depreciation and amortization that is recognized in cost of goods sold. |
|
(10) |
Primarily reflects cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260430670249/en/
216-676-2000
investor.relations@graftech.com
Source: